Cardiovascular Drugs — Flashcards

_____ is a soluble guanylate cyclase stimulator, indicated in the treatment of pulmonary artery hypertension.

Cardiovascular (Antiarrhythmics) _____ is a first line agent for acute treatment of supraventricular arrhythmias

Hydralazine is contraindicated in patients with _____ and CAD

Because Class IC antiarrhythmics have a strong binding affinity and dissociate primarily during diastole, an _____ heart rate results in an increased QRS complex

_____ is a newer antiarrhythmic agent indicated in atrial fibrillation.

PCSK9 Inhibitors (_____ and evolocumab) work by inactivating LDL-receptor degradation, resulting in a dramatic decrease in LDL

Calcium Channel Blockers (CCBs) _____ CCBs may be used to treat Raynaud's phenomenon, which is an exaggerated vascular response to cold temperature or emotional stress

Class I_____ antiarrhythmics may have proarrhythmic effects and are thus contraindicated in patients with structural heart disease or ischemic heart disease

_____ is a selective endothelin receptor A (ET A) antagonist which is used in the management of pulmonary artery hypertension

Digoxin exerts parasympathomimetic effects via direct stimulation of the _____ nerve, causing AV nodal inhibition